Walters William T 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 12:44 pm Purchase | 2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 7,050,000 9.900% | 550,000 (+8.46%) | Filing |
| 2025-01-22 10:08 am Purchase | 2025-01-21 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 6,500,000 9.100% | 1,500,000 (+30.00%) | Filing |
| 2025-01-08 6:49 pm Purchase | 2025-01-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 5,000,000 7.000% | 1,000,000 (+25.00%) | Filing |
| 2024-12-10 12:42 pm Purchase | 2024-12-03 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 4,000,000 5.600% | 4,000,000 (New Position) | Filing |